US Govt Purchases Additional 50M Doses of Pfizer (PFE) and BioNTech (BNTX) COVID-19 Vaccine
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/30/2026
- S&P 500, Nasdaq register best quarter since 2020 despite Iran war
- Dollar pushes higher, yen sinks to 40-year low
- NVIDIA stock gains as SemiAnalysis sees H2 data center revenue 20% above consensus
- Citi says bearish flows are building in Nasdaq and S&P 500
- Patrick and LCI Industries to merge in all-stock deal
- Mizuho says ignore Apple noise, flags key catalyst for Micron and memory in H2
- EchoStar Prepares Dish DBS Bankruptcy Filing as Soon as Tuesday - WSJ
- Strategy stock jumps 7% as firm shifts to active capital management
- New leader board: Citi refreshes AI compute semiconductor picks
- Honeywell completes aerospace spin-off, splits into 3 companies
Pfizer (PFE) and BioNTech (BNTX) COVID-19 Vaccine Receives FDA Emergency Use Authorization for Children Aged 5-11
October 29, 2021 5:46 PM EDTPfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced that the U.S. Food and Drug Administration (FDA) has authorized for emergency use the Pfizer-BioNTech COVID-19 Vaccine for children 5 through 11 years of age (also referred to as 5 to... More
Volatility Skew call IV above put IV
October 28, 2021 4:24 AM EDTPfizer (NYSE: PFE) volatility skew call IV above put IV
... MoreFDA AdCom Votes in Favor of Emergency Use Authorization for Pfizer (PFE) and BioNTech's (BNTX) Covid-19 Vaccine in Children 5 to <12 Years
October 27, 2021 5:51 AM EDTTrillium Therapeutics (TRIL) Shareholders Approve Takeover by Pfizer
October 26, 2021 5:15 PM EDTTrillium Therapeutics Inc. (NASDAQ: TRIL), a clinical stage immuno-oncology company developing innovative therapies for the treatment of cancer, today announced that its securityholders approved a statutory arrangement with PF Argentum ULC (PF Argentum) a wholly-owned, indirect subsidiary of Pfizer Inc. (NYSE: PFE) (Pfizer) at the special meeting of Trillium securityholders today. Pursuant to the arrangement, PF Argentum will acquire all of the issued and outstanding shares and warrants of Trillium, other than... More
U.S. FDA advisers vote in favor of Pfizer/BioNTech COVID-19 vaccine in young kids
October 26, 2021 4:23 PM EDT(Reuters) - A panel of outside advisers to the U.S. Food and Drug Administration on Tuesday voted to recommend the Pfizer Inc and BioNTech SE COVID-19 vaccine for children ages five to 11 years.
(Reporting by Manas Mishra in Bengaluru; Editing by Bill Berkrot)
... MorePfizer (PFE) Covid Shot For Kids Age 5-11 Gets FDA Panel's Backing - Bloomberg
October 26, 2021 4:18 PM EDTPfizer (NYSE: PFE) Covid Shot For Kids Age 5-11 Gets FDA Panel's Backing - Bloomberg
... More